
Gut Bacteria Changes May Signal Type 1 Diabetes Risk in Children and Adults
New research shows that children and adults with Type 1 diabetes have distinct changes in their gut bacteria and the substances those bacteria produce. These differences could one day help identify people at risk before diagnosis.
Evidence label explains the kind of source behind this article (for example peer-reviewed literature vs community video). It is not medical advice.
Key takeaways
- Children who develop severe Type 1 diabetes with diabetic ketoacidosis show specific gut bacteria patterns different from other children
- Adults with newly diagnosed Type 1 diabetes have depleted levels of bacteria that produce short-chain fatty acids, especially a bacterium called Eubacterium rectale
- Adults with Type 1 diabetes lack certain metabolites—chemical compounds produced by bacteria—that are involved in glucose metabolism and pancreatic immune function
- A combination of six specific bacteria and six metabolites could potentially distinguish Type 1 diabetes from Type 2 diabetes and healthy individuals with high accuracy
What Researchers Found
A study of 218 adults and children compared gut bacteria composition between people with Type 1 diabetes, Type 2 diabetes, and healthy individuals. Using genetic sequencing and metabolite testing, researchers identified clear differences in the gut bacterial communities of Type 1 diabetes patients.
The most striking finding was a significant depletion of bacteria that produce short-chain fatty acids—compounds important for gut and metabolic health. Eubacterium rectale, one of these beneficial bacteria, was notably reduced in people with Type 1 diabetes.
Missing Metabolites and What They Mean
Beyond bacteria counts, the study measured metabolites—chemical substances produced when bacteria break down food. People with Type 1 diabetes showed severe losses in phenolic acids and their derivatives.
Two metabolites stood out: gallic acid, which plays a role in glucose metabolism, and 3,4-dihydroxyhydrocinnamic acid, which is linked to both glucose metabolism and pancreatic beta cell autoimmunity. This connection to immune function is particularly significant because Type 1 diabetes develops when the immune system attacks insulin-producing beta cells.
A Potential Diagnostic Tool
When researchers combined information about six specific bacteria and six metabolites into a predictive model, they could distinguish Type 1 diabetes from Type 2 diabetes and healthy individuals with high accuracy. This suggests a measurable biological signature exists for Type 1 diabetes.
This does not yet mean such a test is available to patients. The findings point toward a future possibility, but more research is needed to confirm these patterns in larger populations and determine how useful this information might be for early detection or risk assessment.
Why This Matters
Understanding the gut bacteria changes associated with Type 1 diabetes opens new avenues for research. A non-invasive test based on gut bacteria could potentially help identify people at risk before symptoms appear, though that possibility remains preliminary.
The research also highlights that Type 1 diabetes—long thought primarily a childhood disease—occurs frequently in adults, and these adult-onset cases show the same gut bacteria alterations as children. This broader understanding may help improve early detection and risk assessment across all age groups.
Evidence label
Origin: Type1Cure (Video report). Evidence: Video report, corroborated with 1 indexed study. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.
Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.
Related reading
More evidence-labeled coverage across the Type1Cure library.
- Diagnosis & Early DetectionWhat Happens to Quality of Life and Emotions Right After Type 1 Diagnosis?
- Diagnosis & Early DetectionWhat People with Type 1 Diabetes in South Africa Really Think About Continuous Glucose Monitoring
- Diagnosis & Early DetectionWhen Cancer Treatment Triggers Type 1 Diabetes: What Patients Should Know
- Diagnosis & Early DetectionWhat Claims Data Reveals About DKA at Type 1 Diabetes Diagnosis
- Diagnosis & Early DetectionWhen Grief Masks a Medical Emergency: A Case of Type 1 Diabetes Going Unrecognized
- Diagnosis & Early DetectionWhat Parents Want You to Know About Repeated Glucose Monitoring for Children at Diabetes Risk